Click Here to return To Results

 

Antithrombotic Therapy and Bleeding Risk in a Prospective Cohort Study of Patients with Cerebral Cavernous Malformations Stroke 43:3196-3199, Schneble, H.,et al, 2012 See this aricle in Pubmed Article Abstract Our observational data suggest that long-term antithrombotic treatment by antiplatelet drugs or warfarin does not increase the frequency of CCM-related hemorrhage. Patients harboring single or multiple CCMs suffering ischemic stroke or heart disease should not be withheld antithrombotic therapy.

Related Tags

(click to filter results - removes previous filter) anticoagulant,treatment aspirin cavernous hemangioma complications coumarin intracerebral hemorrhage malformation,vascular malformation,vascular,cerebral platelet inhibiting drugs risk factors safety

Click Here to return To Results